Why is Orchid Pharma falling/rising?

As of 19-Aug, Orchid Pharma Ltd's stock price is currently at 758.85, reflecting an increase of 5.95 (0.79%). The stock has shown a positive performance today, outperforming its sector by 0.92% and has gained 1.52% over the last two days. However, the stock's performance over the past week has been negative, with a decline of 0.75%, while it has increased by 3.47% over the past month. Despite these short-term gains, the stock has significantly underperformed in the long term, with a year-to-date decline of 58.24% and a one-year drop of 46.51%. The company has high institutional holdings at 20.82%, which may provide some stability, but it also faces weak long-term fundamentals, including a low return on equity (ROE) of 4.68% and a concerning EBIT to interest ratio of 1.99.
In the broader market context, the Sensex has shown a positive return of 1.76% over the past week and a 4.49% increase year-to-date, indicating that the overall market is performing better than Orchid Pharma. While the stock has experienced a slight uptick recently, it remains significantly below the benchmark's performance over the past year, where the market has only declined by 0.91%. The company's recent negative financial results, including a 19.64% drop in operating profit and three consecutive quarters of negative results, contribute to its weak long-term outlook, further exacerbating its underperformance relative to the market.